What's New

Press Releases

Target ALS and AFTD Announce Groundbreaking Partnership to Spur Drug and Biomarker Development for ALS and FTD

Today, The Association for Frontotemporal Degeneration (AFTD) and Target ALS announced a groundbreaking partnership and call for proposals to identify treatments and biomarkers for FTD and ALS. These two devastating, progressive diseases are now understood to overlap in genetic causes…


Third Annual AFTD Benefit Draws Largest Attendance to Date, Raises over $1.9 Million, in Support of Frontotemporal Degeneration Research, Support and Awareness

AFTD held its annual Hope Rising Benefit on Wednesday, October 17. The benefit drew its highest attendance since the first gala in 2016, and raised more than $1.9MM to fuel AFTD’s mission of advancing FTD research and improving quality of…